TrialPain medicine (Malden, Mass.)2017

Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial.

Lynn R Webster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.